FDA Adverse Event Death Summary report: N

FLOWTRIEVER RETRIEVAL ASPIRATION SYSTEM

MDR report key: 8146445 · Received December 10, 2018

Report

Report Number
3011525976-2018-00002
Event Type
Death
Date Received
December 10, 2018
Date of Event
November 12, 2018
Report Date
December 10, 2018
Manufacturer
INARI MEDICAL, INC.
Product Code
DXE
UDI-DI
00850291007079
PMA / PMN Number
K182233
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MI, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE WAS DISCARDED BY THE USER FACILITY AND IS THEREFORE NOT AVAILABLE FOR ANALYSIS. THERE WAS NO REPORT OF A DEVICE MALFUNCTION. THE DEVICE HISTORY RECORDS FOR THIS MANUFACTURING LOT WERE REVIEWED AND THERE WERE NO ANOMALIES, DISCREPANCIES, OR NON-CONFORMANCES. THE LIKELY ROOT CAUSE OF THE EVENT WAS ATTRIBUTED TO POSSIBLE INADVERTENT DISLODGING OF PREEXISTING CLOT EMBOLIZING THE TRUNCUS ANTERIOR. HYPOXEMIA AND DEATH ARE LISTED IN THE DEVICE LABELING AS POTENTIAL COMPLICATIONS ASSOCIATED WITH THROMBECTOMY PROCEDURES. MANUFACTURER REFERENCE #: (B)(4).

Description of Event or Problem · 1

ON (B)(6) 2018, THE PATIENT PRESENTED IN THE EMERGENCY DEPARTMENT WITH A CLOT IN THE LUNGS. CT ANGIOGRAPHY CONFIRMED A SADDLE, BILATERAL PULMONARY EMBOLUS WITH ALMOST COMPLETE OBSTRUCTION OF THE RIGHT PULMONARY ARTERY (PA). THE FOLLOWING DAY THE PATIENT BEGAN DECOMPENSATING IN THE CARDIOVASCULAR INTENSIVE CARE UNIT (CVICU) THEN STABILIZED; RIGHT VENTRICLE/LEFT VENTRICLE (RV/LV) RATIO WAS ELEVATED AT 2.1, SAO2: 92 (ON 15L OF OXYGEN), HR: 105, BP: 116/71, AND PULMONARY ARTERY PRESSURE WAS ELEVATED 69/27/41 (SYSTOLIC/DIASTOLIC/MEAN MMHG). IT SHOULD BE NOTED THAT WHILE THE PATIENT HAD BEEN ON 15L OF OXYGEN IN THE CVICU, THIS WAS DECREASED TO 4L VIA NASAL CANNULA DURING THE THROMBECTOMY PROCEDURE WHICH MAY HAVE PREDISPOSED THE FOLLOWING HYPOXEMIC EVENT. THE PHYSICIAN GAINED ACCESS USING THE ASPIRATION GUIDE CATHETER (AGC) VIA ULTRASOUND AND CROSSED THE HEART WITH A BALLOON-TIPPED CATHETER. HEMODYNAMIC MEASUREMENTS AND PULMONARY ANGIOGRAPHY REVEALED A SUBSTANTIAL CLOT IN THE RPA (NO ANGIOGRAPHY OF THE LEFT PULMONARY ARTERY AT THIS TIME). THREE VACUUM ASPIRATIONS USING THE 60 CC SYRINGE (SUPPLIED AS PART OF THE AGC SYSTEM) RETRIEVED SUBSTANTIAL CLOT WITH EACH ATTEMPT; BLOOD LOSS WAS 20 CC PER ATTEMPT. AFTER THE THIRD ASPIRATION, THE AGC WAS REMOVED AND PULMONARY ANGIOGRAPHY REVEALED INITIAL REPERFUSION OF THE MIDDLE AND INFERIOR LOBES. THE AGC WAS RE-INSERTED AND PLACED AT THE BIFURCATION OF THE MIDDLE AND INFERIOR LOBAR BRANCHES; UPON PLACEMENT OXYGEN DESATURATED AND THE PATIENT SEIZED (BELIEVED TO BE CAUSED BY HYPOXIA). THE PATIENT DETERIORATED FURTHER AND A CODE WAS CALLED. DURING CHEST COMPRESSIONS ANOTHER PULMONARY ANGIOGRAM WAS PERFORMED. THE PHYSICIAN SUSPECTED A PERFORATION ALTHOUGH THERE WAS NO EXTRAVASATION IDENTIFIED DURING CINEANGIOGRAPHY, NO PRIOR HEMOPTYSIS, AND NO EVIDENCE OF BLEEDING DURING CPR. RADIOLOGY CONFIRMED NO PERFORATION HAD OCCURRED. CPR CONTINUED FOR APPROXIMATELY 20 MINUTES AND THE PATIENT STABILIZED. THE EKOSONIC ENDOVASCULAR SYSTEM WAS DEPLOYED TO REDUCE CLOT BURDEN. ON (B)(6) 2018, THE PHYSICIAN REPORTED THAT THE PATIENT WAS STABLE IN THE CVICU AND WAKING UP, BUT WAS ON "VASOPRESSERS". AFTER REVIEWING THE FINAL PULMONARY ANGIOGRAM IT WAS NOTED THAT THE TRUNCUS ANTERIOR (TA) WHICH WAS PRESENT AT THE BEGINNING OF THE PROCEDURE WAS NO LONGER VISIBLE. IT WAS SUSPECTED THAT DURING MANIPULATION OF THE AGC THE CLOT MAY HAVE DISLODGED AND EMBOLIZED THE TA, CAUSING THE PATIENT TO BECOME HYPOXIC. THERE WAS NO REPORT OF A DEVICE MALFUNCTION. ON NOVEMBER 19, 2018, INARI RECEIVED INFORMATION THAT THE PATIENT HAD EXPIRED. ADDITIONAL INFORMATION IS BEING REQUESTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
985674 FLOWTRIEVER RETRIEVAL ASPIRATION SYSTEM EMBOLECTOMY CATHETER DXE INARI MEDICAL, INC. 21-101 18090003 00850291007079

Patients

Seq Age Sex Outcome Treatment
1 75 YR Death EKOSONIC ENDOVASULAR SYSTEM